Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 208, Issue 1, Pages 167-180Publisher
ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20101850
Keywords
-
Categories
Funding
- National Institutes of Health [R01 AI-15608, R01 AI-37293, R01 HL-33391, U-19 AI-83024, T32 AI007496-13]
Ask authors/readers for more resources
Cytotoxic T lymphocytes (CTLs) play a prominent role in the resolution of viral infections through their capacity both to mediate contact-dependent lysis of infected cells and to release soluble proinflammatory cytokines and chemokines. The factors controlling these antiviral effector activities in vivo at infection sites are ill defined. Using a mouse model of influenza infection, we observed that the expression of CTL effector activity in the infected lungs is dictated by the target cell type encountered. CD45(+) lung infiltrating inflammatory mononuclear cells, particularly CD11c(hi) dendritic cells, trigger both CTL cytotoxicity and release of inflammatory mediators, whereas CD45(-) influenza-infected respiratory epithelial cells stimulate only CTL cytotoxicity. CTL proinflammatory mediator release is modulated by co-stimulatory ligands (CD80 and CD86) expressed by the CD45(+) inflammatory cells. These findings suggest novel mechanisms of control of CTL effector activity and have potentially important implications for the control of excess pulmonary inflammation and immuno-pathology while preserving optimal viral clearance during respiratory virus infections.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available